Article

New PCSK9 Approval, Biosimilar Cost Tops Specialty Pharmacy Week in Review

Author(s):

Davy James, Managing Editor

Top stories of the week on Specialty Pharmacy Times.

[<a href="//storify.com/pharmacytimes/pcsk9-approval-biosimilar-cost" target="_blank">View the story "New PCSK9 Approval, Biosimilar Cost Tops Specialty Pharmacy Week in Review" on Storify</a>]

Related Videos
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards
Image Credit: © utah51 - stock.adobe.com
October is American Pharmacists Month.
smiling indian male doctor or pharmacist in white coat with stethoscope and clipboard over drugstore background
Patient taking prescription medicine -- Image credit: Rawpixel.com | stock.adobe.com
Efficient healthcare supply chain management ensures timely delivery of medical supplies and medications
Pharmacy Benefit Manager Transparency | Image Credit: I Viewfinder - stock.adobe.com
Pharmacy Benefit Manager Regulation | Image Credit: Tyler Olson - stock.adobe.com
Naloxone concept represented by wooden letter tiles.
Related Content
Biosimilar, Ocrelizumab, Multiple Sclerosis | Image Credit: ralwel - stock.adobe.com
November 12th 2024

Proposed Biosimilar to Ocrelizumab Shows Comparability With Reference Product

Ashley Gallagher, Associate Editor
Pharmacy Focus: World Psychedelics Day
June 14th 2024

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Associate Editor
Spinal health visualization Individual suffering spinal muscular dystrophy glowing depiction of progressive muscle weakness affecting the spine
November 8th 2024

FDA Grants Orphan Drug Designation to Ifetroban for Treatment of Duchenne Muscular Dystrophy-Associated Cardiomyopathy

Luke Halpern, Assistant Editor
Season 3 - Public Health Matters: A Look at Wearable Technology, AI-Assisted Innovations
January 25th 2024

Season 3 - Public Health Matters: A Look at Wearable Technology, AI-Assisted Innovations

Biosimilar Pegfilgrastim, Bone Marrow, Oncology, Cancer | Image Credit: Shutter2U - stock.adobe.com
November 5th 2024

Pegfilgrastim-Fpgk Shows Structural, Functional Biosimilarity to Reference Product

Ashley Gallagher, Associate Editor
Blood sample for hemophagocytic lymphohistiocytosis(HLH) genetic analysis, HLH is a potentially fatal disease characterized by abnormal activation of T-lymphocytes and macrophages - Image credit: MdBabul |stock.adobe.com
November 4th 2024

ELA026 Receives Orphan Drug Designation to Treat Hemophagocytic Lymphohistiocytosis

Kennedy Ferruggia, Assistant Editor